 |
|
|
| |
High sustained virological response rates using generic direct
antiviral treatment for Hepatitis C REDEMPTION-1
|
| |
| |
Reported by Jules Levin
EASL 2016
James Freeman1, Richard Sallie2, Adam Kennedy3, Pham Thi Ngoc Nieu1, John Freeman4, Greg Jeffreys5, Andrew M. Hill6
1GP2U Telehealth, Hobart, 2Hepatology, Nedlands, 3Kingswood Pharmacy, 4Nephrology, Sandy Bay, 5University of Tasmania, Hobart, Australia, 6St Stephens AIDS Trust, Chelsea and Westminster Hospital, London, United Kingdom
International Liver Congress 2016 13-18 April, Barcelona, Spain
1.http://www.who.int/mediacentre/factsheets/fs164/en/
2.http://www.unitaid.eu/images/marketdynamics/publications/Hepatitis_C_Medicines_Technology_and_Market_Landscape__Update.pdf
3.http://www.bidnessetc.com/59228-gilead-sciences-inc-abbvie-inc-finally-see-growth-in-hcv-prescription-volum/
EASL: New York Insurers to Change Coverage of Hepatitis C Drugs - (04/26/16)
1.Hill A. Minimum Costs for Producing Hepatitis C Direct-Acting Antivirals. Clin Inf Dis. 2014
2.https://www.tga.gov.au/personal-importation-scheme
3.https://www.gov.uk/government/organisations/hm-revenue-customs
For interest here is an NMR spectrum of some generic sofosbuvir. NMR is one of a range of techniques, such as
High Performance Liquid Chromatography, Mass Spectrometry and X-ray crystallography that can establish the
precise nature and purity of a medication.
|
| |
|
|
|
|
|
